Glucagon-like peptide-1 analogues for overweight or obese adults

Madrid, EvaOcara Vargas, MirandaContreras-Vera, CatalinaSaldías, CristinaEscobar Liquitay, Camila MicaelaNovik A, VictoriaMunoz, Sergio R.Bracchiglione, Javier2024-04-122024-04-122022-09-08Cochrane Database of Systematic Reviews, Volume 2022, Issue 9, 8 September 2022, Article number CD0150921465-1858https://repositorio.unab.cl/handle/ria/55904Indexación: Scopus.Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of glucagon-like peptide-1 analogues on overweight or obese adults. Copyright © 2022 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.enGlucagon like peptide 1Hemoglobin A1cAbdominal discomfortAdultArticleBody massCardiovascular riskCerebrovascular accidentConstipationDiarrheaDyslipidemiaDyspepsiaEnergy expenditureFollow upFood intakeHumanHypertensionNauseaNon insulin dependent diabetes mellitusObesityOutcome assessmentPhysical activityPrevalenceQuality of lifeRandomized controlled trial (topic)Risk assessmentRisk factorSensitivity analysisSleep disordered breathingVomitingGlucagon-like peptide-1 analogues for overweight or obese adultsArtículoCC BY 4.0 DEED Atribución 4.0 Internacional10.1002/14651858.CD015092